Dr. Arturo Urrios

Dr. Arturo Urrios



Arturo joined Wellington Partners in 2019 as an Associate in the Life Science Team.

Arturo holds a BSc in Human Biology, an MSc in Biomedical Research, a PhD in Biomedicine and an MBA.

Arturo performed his thesis in the Cell Signaling Research Group at Pompeu Fabra University, Barcelona and the Folch lab at University of Washington, Seattle, in the fields of synthetic biology, biological computation, 3D printing and microfluidics, resulting in several publications in prestigious journals. During his academic trajectory, he received multiple distinctions such as a National graduation award, La Caixa PhD fellowship, EMBO short term fellowship and an extraordinary PhD award.

Prior to joining Wellington, Arturo completed postdoctoral studies developing synthetic biology approaches for type 1 diabetes treatment while starting a personal project as a winemaker and freelancing in different start-ups aiding with strategy and business development. Thereafter, he joined the Life Science Team of M Ventures, Netherlands, as an Investment Analyst, where he was involved in several investments including Riffyn and DNA Script.